ACTUATE THERAPEUTICS, INC.
Pharmaceutical Preparations · FORT WORTH
Moderate confidence (50%)
Updated Oct 15, 2026, 12:01 AM
What is happening
Derived by rule set status-rules-2026.09.7
An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.
Latest material event: ACTUATE THERAPEUTICS, INC. received a delisting notice from its exchange (Jul 15, 2026)
Timeline
Every material event, newest first. History is never overwritten.
ACTUATE THERAPEUTICS, INC. received a delisting notice from its exchange
Jul 15, 2026
Delisting notice received
- SEC EDGAR — “Item 3.01 Notice of Delisting or Failure to Satisfy Continued Listing Rule or Standard; Transfer of Listing. On July 15, 2026, Actuate Therapeutics, Inc. (the Company ) received a letter (the Notice ) from the listing qualifications department staff (the Staff ) of The Nasdaq Stock Market ( Nasdaq ) notifying the Company that that from June 1, 2026 to July 14, 2026, the Company s Market Value of Listed Securities ( MVLS ) was below the minimum of $50 million required for continued listing on The Nasdaq Global Market pursuant to Nasdaq Listing Rule 5450(b)(2)(A) (the MVLS Requirement ). The Not…”
Company information
- Founded
- —
- Employees (estimate)
- —
- Industry
- Pharmaceutical Preparations
- Subindustry
- —
- Listing
- SEC lists the ticker ACTU on Nasdaq.
- SEC CIK
- 0001652935
- Website
- —
- —
- Headquarters
- FORT WORTH
- Also known as
- —
- Legal entities
- ACTUATE THERAPEUTICS, INC.
Sources
Every material source used to build this profile.
SEC Company Submissions (TIER 1 · UNVERIFIED)
ACTUATE THERAPEUTICS, INC. — Pharmaceutical Preparations (SIC 2834) — FORT WORTH, TX
View source recordSEC EDGAR (TIER 1 · UNVERIFIED)
Item 3.01 Notice of Delisting or Failure to Satisfy Continued Listing Rule or Standard; Transfer of Listing. On July 15, 2026, Actuate Therapeutics, Inc. (the Company ) received a letter (the Notice ) from the listing qualifications department staff (the Staff ) of The Nasdaq Stock Market ( Nasdaq ) notifying the Company that that from June 1, 2026 to July 14, 2026, the Company s Market Value of Listed Securities ( MVLS ) was below the minimum of $50 million required for continued listing on The Nasdaq Global Market pursuant to Nasdaq Listing Rule 5450(b)(2)(A) (the MVLS Requirement ). The Not…
View source record
Status history
Every derived status, with the rule that produced it.
- DISTRESS_SIGNAL → DISTRESS_SIGNALLISTING_STANDARDS_WARNING · Sep 18, 2026, 01:30 AM
An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.
- DISTRESS_SIGNAL → DISTRESS_SIGNALLISTING_STANDARDS_WARNING · Sep 18, 2026, 01:11 AM
An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.
- DISTRESS_SIGNAL → DISTRESS_SIGNALPUBLIC_LISTING_ENDED · Sep 15, 2026, 12:33 PM
An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.
- DISTRESS_SIGNAL → DISTRESS_SIGNALPUBLIC_LISTING_ENDED · Sep 12, 2026, 12:04 AM
An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.
- DISTRESS_SIGNAL → DISTRESS_SIGNALPUBLIC_LISTING_ENDED · Sep 11, 2026, 12:02 AM
An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.
- UNKNOWN → DISTRESS_SIGNALPUBLIC_LISTING_ENDED · Sep 8, 2026, 03:22 AM
An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.